Literature DB >> 10594760

Identification of a novel mutation R42P in the gap junction protein beta-3 associated with autosomal dominant erythrokeratoderma variabilis.

A Wilgoss1, I M Leigh, M R Barnes, P Dopping-Hepenstal, R A Eady, J M Walter, C T Kennedy, D P Kelsell.   

Abstract

We report a missense mutation in the gap junction protein beta-3 (encoding Connexin 31), which was detected in only the affected members of a family in which the autosomal dominant skin disease erythrokeratoderma variabilis was segregating. The nucleotide change results in an arginine to proline substitution in codon 42. This residue is positioned on the first transmembrane/first extracellular domain of the gap junction protein with the mutation replacing a negatively charged residue with a nonpolar residue. This change may disrupt the conformation of the protein and voltage gating polarity leading to impaired channel function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10594760     DOI: 10.1046/j.1523-1747.1999.00792.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

Review 1.  Connexin mutations in skin disease and hearing loss.

Authors:  D P Kelsell; W L Di; M J Houseman
Journal:  Am J Hum Genet       Date:  2001-01-25       Impact factor: 11.025

2.  A novel N14Y mutation in Connexin26 in keratitis-ichthyosis-deafness syndrome: analyses of altered gap junctional communication and molecular structure of N terminus of mutated Connexin26.

Authors:  Ken Arita; Masashi Akiyama; Tomoyasu Aizawa; Yoshitaka Umetsu; Ikuo Segawa; Maki Goto; Daisuke Sawamura; Makoto Demura; Keiichi Kawano; Hiroshi Shimizu
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 3.  Do cell junction protein mutations cause an airway phenotype in mice or humans?

Authors:  Eugene H Chang; Alejandro A Pezzulo; Joseph Zabner
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-04       Impact factor: 6.914

4.  Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis.

Authors:  F Macari; M Landau; P Cousin; B Mevorah; S Brenner; R Panizzon; D F Schorderet; D Hohl; M Huber
Journal:  Am J Hum Genet       Date:  2000-10-03       Impact factor: 11.025

5.  Erythrokeratoderma variabilis (EKV) - First Nepalese case documenting GJB3 mutation.

Authors:  M Shah; S Baral; R C Adhikari
Journal:  Skin Health Dis       Date:  2021-08-17

6.  EKV mutant connexin 31 associated cell death is mediated by ER stress.

Authors:  Daniel Tattersall; Claire A Scott; Colin Gray; Daniel Zicha; David P Kelsell
Journal:  Hum Mol Genet       Date:  2009-09-14       Impact factor: 6.150

Review 7.  The role of connexins in ear and skin physiology - functional insights from disease-associated mutations.

Authors:  Ji Xu; Bruce J Nicholson
Journal:  Biochim Biophys Acta       Date:  2012-07-13

Review 8.  Improving hearing loss gene testing: a systematic review of gene evidence toward more efficient next-generation sequencing-based diagnostic testing and interpretation.

Authors:  Ahmad N Abou Tayoun; Saeed H Al Turki; Andrea M Oza; Mark J Bowser; Amy L Hernandez; Birgit H Funke; Heidi L Rehm; Sami S Amr
Journal:  Genet Med       Date:  2015-11-12       Impact factor: 8.822

9.  Pathogenic connexin-31 forms constitutively active hemichannels to promote necrotic cell death.

Authors:  Jingwei Chi; Li Li; Mujun Liu; Jieqiong Tan; Chengyuan Tang; Qian Pan; Danling Wang; Zhuohua Zhang
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

10.  Interrogation of Carboxy-Terminus Localized GJA1 Variants Associated with Erythrokeratodermia Variabilis et Progressiva.

Authors:  Sergiu A Lucaciu; Qing Shao; Rhett Figliuzzi; Kevin Barr; Donglin Bai; Dale W Laird
Journal:  Int J Mol Sci       Date:  2022-01-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.